InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（7 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
7
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Browse the detailed record of transactions filed by Williams Lewis T, Directeur. Director active across 3 companies, notably Arcellx, Inc.. In total, 13 reports have been logged. Breakdown: 0 buy · 7 sells. Activity tracked since 8 February 2022. The latest transaction was disclosed on 17 February 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Williams Lewis T
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报13 总计
18,000 股@ US$10.84100.0% 占其流量Common StockSEC:0001104659-26-017176:0
2,695 股0Common StockSEC:0001104659-26-001476:0
5,130 股0Common StockSEC:0001104659-25-001432:0
2,095,114 股0Common StockSEC:0001209191-22-008160:0
4,528 股Common StockSEC:0001123292-16-001685:7
35,615 股Common StockSEC:0001123292-16-001685:0
20,086 股Common StockSEC:0001123292-16-001685:1
11,800 股Common StockSEC:0001123292-16-001685:2
3,729 股Common StockSEC:0001123292-16-001685:3
35,614 股Common StockSEC:0001123292-16-001685:4
18,557 股Common StockSEC:0001123292-16-001685:5
12,408 股Common StockSEC:0001123292-16-001685:6
121 股Common StockSEC:0001123292-16-001685:8
13 条申报中的 13 条
About Williams Lewis T
Williams Lewis T is a Director and has 13 filings in total. In the sampled recent filings, the period runs from 2016-02-08 to 2026-02-18, and the modal transaction nature is shown as Disposal. The companies mentioned are FIVE PRIME THERAPEUTICS INC, where he is President and CEO, Protagonist Therapeutics, Inc, where he is Director, and Arcellx, Inc., where he is Director.
